| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alumis Inc. (ALMS) has 17 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. ALMS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 15.14M | $355.63M | - | |
| 10% | 5.70M | $133.95M | - | |
| 10% | 2.91M | $68.32M | - | |
| 10% | 2.91M | $68.32M | - | |
| Dir | 1.85M | $43.54M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | Colowick Alan | Director | Buy | 18,404 | $7.04 | $129,544.35 | +114.3% | -69.3% | +137.5% | |
| Apr 1, 2025 | Babler Martin | President, CEO And Chairman | Buy | 15,650 | $6.44 | $100,732.79 | +17.2% | -58.6% | +214.0% | |
| Jul 1, 2024 | Tananbaum James B. | Director, 10% Owner | Buy | 2,500,000 | $16.00 | $40,000,000.00 | +34.3% | -14.8% | -75.9% | |
| Jul 1, 2024 | Foresite Capital Management V, LLC | 10% Owner | Buy | 2,500,000 | $16.00 | $40,000,000.00 | +34.3% | -14.8% | -75.9% | |
| Jul 1, 2024 | Foresite Labs, LLC | 10% Owner | Buy | 2,500,000 | $16.00 | $40,000,000.00 | +34.3% | -14.8% | -75.9% |